USSTOCK.TODAY
Market Closed
Log in Sign up

Pulmatrix Inc(PULM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

PULM
PULM
Pulmatrix Inc
At close Nov 19 at 4:00 PM ET (Korea 11/20 06:00)
$1.42
+0.08 ▲ +5.97%
Nov 19 at 4:25 PM ET (Korea 11/20 06:25)
$1.33
-0.09 ▼ -6.61%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -1.2Insider Own ⓘ -Shs Outstand ⓘ 3.6MPerf Week ⓘ 9.24%
Market Cap ⓘ 0.01BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 3.6MPerf Month ⓘ -9.55%
Enterprise Value ⓘ 0.00BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 9.9%Short Float ⓘ 1.08%Perf Quarter ⓘ -5.02%
Income ⓘ -0.00BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ 4.06%Short Ratio ⓘ 1.23Perf Half Y ⓘ 3.65%
Sales ⓘ 0.00BP/B ⓘ 14.45EPS next 5Y ⓘ -ROA ⓘ -118.42%Short Interest ⓘ 0.04MPerf YTD ⓘ -36.32%
Book/sh ⓘ 0.1P/C ⓘ 2.47EPS past 3/5Y ⓘ 36.28% 36.26%ROE ⓘ -143.08%52W High ⓘ -71.26% ($4.94)Perf Year ⓘ -67.58%
Cash/sh ⓘ 0.58P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -323.11%52W Low ⓘ 33.96% ($1.06)Perf 3Y ⓘ -21.76%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 29.48%Gross Margin ⓘ -Volatility(W/M) ⓘ 9.34% 10.96%Perf 5Y ⓘ -89.71%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -100%Oper. Margin ⓘ -ATR (14) ⓘ 0.13Perf 10Y ⓘ -99.08%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 2.32EPS Q/Q ⓘ -40.73%Profit Margin ⓘ -RSI (14) ⓘ 51.79Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 2.32Sales Q/Q ⓘ -SMA20 ⓘ 2.09% ($1.39)Beta ⓘ 1.9Target Price ⓘ $10
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ 2026/11/17SMA50 ⓘ -2.33% ($1.45)Rel Volume ⓘ 5.38Prev Close ⓘ $1.34
Employees ⓘ 2LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -12.72% ($1.63)Avg Volume(3M) ⓘ 0.03MPrice ⓘ $1.42
IPO ⓘ 2014/3/21Option/Short ⓘ No/YesTrades ⓘ 464Volume ⓘ 172,681Change ⓘ 5.97%
Company
PULM PULMPulmatrix Inc | NASD | Biotechnology Deep dive

Pearl Bio (), or PearlMatrix, is a US clinical-stage biotech company that has been developing drug candidates targeting chronic obstructive pulmonary disease (COPD), fungal lung infections, and migraines, built around its proprietary inhalable dry powder formulation platform called 'iSPERSE.' It is a micro-cap stock with virtually no revenue, currently undergoing a business restructuring through mergers and asset divestitures.

Quote

Over the past 1 year, on the lower side

71% below its 1-year high.

Now $1.42
52w low$1.0652w high$4.94
52W Range9%
Volume ⓘ 172,681

Traded more than usual. That is 538% of its average volume.

C
Overall · average, with some caution
We judged 4 of the 8 questions below. 2 need caution.
No data for growth, valuation, outlook, dividends, or not applicable.
ETFs holding this stock 3 ETFs

Multiple ETFs hold this stock, but only a sliver

Buying this ETF gives you exposure to this stock as well.

Peer comparison Biotechnology

It ranks #539 of 598 in the industry

Based on market cap of $5M.

FAQ

FAQ

What kind of company is PULM?

PULM belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of PULM?

The market cap of PULM is approximately $5M, ranking 5,553 within its sector.

What is the 52-week high and low for PULM?

PULM has recorded a 52-week high of $4.94 and a low of $1.06.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels